Journal
ENVIRONMENTAL HEALTH
Volume 18, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12940-019-0541-z
Keywords
Perfluoroalkyl substances; PFAS; Prenatal exposure; Asthma; The Odense Child Cohort; Preschool; Children
Funding
- Danish Council for Independent Research, medical sciences [4004-00352B_FSS, 8020-00123B_FSS]
- Odense University Hospital
- Region of Southern Denmark
- Municipality of Odense
- Mental Health Service of the Region of Southern Denmark
- Odense University Hospital Research Foundation
- Odense Patient data Explorative Network (OPEN)
- Novo Nordisk Foundation [NNF15OC00017734, NNF17OC0029404]
Ask authors/readers for more resources
Background Asthma is the most common non-communicable disease in children. Prenatal exposure to perfluoroalkyl substances (PFASs), a group of persistent environmental chemicals with endocrine disrupting abilities, has been associated with immunomodulation and may contribute to the aetiology of asthma. We investigated the associations between prenatal exposure to five PFASs and asthma in 5-year-old children. Methods We studied 981 mother-child pairs within the Odense Child Cohort (OCC), Denmark. We measured perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA) in maternal serum donated in early pregnancy. A standardized questionnaire based on the International Study of Asthma and Allergies in Childhood (ISAAC) was used to assess wheeze, self-reported asthma and doctor-diagnosed asthma among children at age 5 years. Associations were examined using logistic regression analyses adjusting for parity, maternal educational level, maternal pre-pregnancy BMI, asthma predisposition and child sex. Results Among the 5-year-old children 18.6% reported wheeze and 7.1% reported asthma. We found no association between prenatal exposure to PFAS and doctor-diagnosed asthma or wheeze. Prenatal PFAS exposure was associated with self-reported asthma, although only significant for PFNA (OR = 1.84, 95% CI 1.03,3.23). Conclusion Our findings support the suggested immunomodulatory effects of PFASs, however, additional studies are warranted. In order to verify our findings, it is important to re-examine the children with postnatal measurements of serum PFAS concentrations and additional clinical diagnostic testing at an older age where an asthma diagnosis is more valid.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available